Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01453088
Title Auto Transplant High Dose Melphalan vs High Dose Melphalan+Bortezomib in Pts With Multiple Myeloma Age 65 Years or Older
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Hackensack University Medical Center
Indications

multiple myeloma

Therapies

Melphalan

Bortezomib

Age Groups: senior
Covered Countries USA


No variant requirements are available.